Profil bibliographique

Laurent Voillat

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

127Publications signalées

8625Citations signalées

0Affiliations récentes

Domaines associés

Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and TreatmentCancer Treatment and PharmacologyChronic Lymphocytic Leukemia ResearchProtein Degradation and Inhibitors

Publications récentes

Accès ouvert 2024 articleOpenAlex

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study

Caroline Dartigeas, Anne Quinquenel, Loïc Ysebaert, Marie‐Sarah Dilhuydy et autres

9 citationsAnnals of Hematology

Accès ouvert 2024 preprintOpenAlex

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study

Caroline Dartigeas, Anne Quinquenel, Loïc Ysebaert, Marie‐Sarah Dilhuydy et autres

0 citationsResearch Square

Accès ouvert 2023 articleOpenAlex

Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group

Sylvain Carras, Alexia Torroja, Anouk Emadali, Émilie Montaut et autres

4 citationsHaematologica

2023 conference-abstractOpenAlex

Lenalidomide Consolidation Improves Measurable Residual Disease (MRD) Rates and Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Following Initial FCR Chemotherapy - Final Analysis of CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)

Thérèse Aurran‐Schleinitz, Stephen P. Mulligan, Rémi Letestu, Marie C. Béné et autres

1 citationBlood

Accès ouvert 2023 articleOpenAlex

Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.

Sylvain Carras, Alexia Torroja, Anouk Emadali, Nicolas Daguindau et autres

0 citationsHematological Oncology

Accès ouvert 2023 articleOpenAlex

Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)

Luc-Mathieu Fornecker, Vincent Delwail, Catherine Thiéblemont, Hervé Ghesquières et autres

0 citationsHematological Oncology

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Tables from Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

Xavier Leleu, Guillemette Fouquet, Valentine Richez, Stéphanie Guidez et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figures from Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

Xavier Leleu, Guillemette Fouquet, Valentine Richez, Stéphanie Guidez et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figures from Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

Xavier Leleu, Guillemette Fouquet, Valentine Richez, Stéphanie Guidez et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

Xavier Leleu, Guillemette Fouquet, Valentine Richez, Stéphanie Guidez et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

Xavier Leleu, Guillemette Fouquet, Valentine Richez, Stéphanie Guidez et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Tables from Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

Xavier Leleu, Guillemette Fouquet, Valentine Richez, Stéphanie Guidez et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.